FUNDAMENTALS · Fundamentals · US Healthcare

CVS Health (CVS) Fundamentals 2026 — P/E 47.1x, Revenue Analysis | SniperIQ

CVS Health (CVS) is a US-listed Healthcare company in Medical - Healthcare Plans with a market capitalization of

39.0B, trading at
08.92 on the NYSE. This SniperIQ fundamentals page covers CVS Health's valuation (P/E 47.1x, P/B 1.8x), profitability (net margin 0.7%), revenue ($402.1B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap
39.0B
P/E (TTM)47.1x
Net Margin0.7%
Revenue (FY25)$402.1B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is CVS Health's market cap?

CVS Health (CVS) has a market capitalization of approximately

39.0B, trading at
08.92 on the NYSE. Market cap moves with the live share price.

What is CVS Health's P/E ratio?

CVS Health's trailing twelve-month P/E ratio is 47.1x, with a price-to-book (P/B) of 1.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is CVS Health?

CVS Health runs a net profit margin of 0.7%, a gross margin of 13.9%, and an operating margin of 1.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does CVS Health generate?

CVS Health reported revenue of $402.1B for fiscal year 2025, with net income of

.8B and earnings per share (EPS) of 1.4. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does CVS Health pay a dividend?

CVS Health offers a trailing dividend yield of about 2.4%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is CVS Health financially healthy?

CVS Health carries a debt-to-equity ratio of 1.01x and a current ratio of 0.87x, with a market beta of 0.60. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is CVS Health a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For CVS Health (CVS) the key facts are: market cap

39.0B, P/E 47.1x, revenue $402.1B, 52-week range 58.5-110.68. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track CVS Health's full fundamentals live

Get CVS Health's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: GNI Group (2160) fundamentals · Dongwha Pharm.Co (000020) fundamentals · PHC Holdings (6523) fundamentals · Vijaya Diagnostic Centre (VIJAYA) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons